The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Case Report: A Polyarteritis Nodosa Conundrum

Case Report: A Polyarteritis Nodosa Conundrum

March 14, 2022 • By Hannah Krebsbach, MD, Ileannette Robledo Vega, MD, Nirupa Patel, MD, & Nkechinyere Emejuaiwe, MD, MPH

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Figure 1: Lower Extremity Ulceration

Figure 1: Lower Extremity Ulceration

Varying stages of ulceration are seen on the left (L) and right (R) lower extremities. An eschar formation is on the left (red arrow), and a superficial ulceration is on the right (black arrow).

You Might Also Like
  • Case Report: Diagnosing, Treating Hepatitis B-Linked Polyarteritis Nodosa
  • Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa
  • Kussmaul, Meier & Polyarteritis Nodosa
Explore This Issue
March 2022

Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries. The clinical subsets of PAN are idiopathic, generalized, secondary hepatitis B virus (HBV) associated and cutaneous PAN. These clinical subsets are important because of their therapeutic implications.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Virtually any organ system can be affected in generalized PAN, but this vasculitis tends to spare the lungs.1 Pleural effusion, transient infiltrates and bronchial artery vasculitis are uncommon manifestations that have been reported in association with PAN.2 These pulmonary manifestations tend to be a reflection of renal or cardiac insufficiency rather than a direct result of the necrotizing vasculitis.

In the case below, we report on the unusual occurrence of shrinking lung syndrome (SLS) and brachial plexopathy in a confirmed case of PAN. This case highlights a broader consideration for the etiology of dyspnea in PAN and adds to the list of immune-mediated diseases associated with SLS and Parsonage-Turner syndrome (PTS).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Case Presentation

A 51-year-old man presented to the hospital with a four-month history of recurrent, bilateral, lower extremity edema and ulcerations that had been treated with intermittent courses of corticosteroids. The ulcers recurred whenever the cortico­steroids were tapered. The patient had experienced fever, dyspnea, orchitis, postprandial abdominal pain, uncontrolled hypertension and intermittent right arm pain during the course of his illness. Just prior to hospitalization he had developed dyspnea. His examination was otherwise unremarkable.

The patient’s past medical history was significant for type 2 diabetes mellitus, hypertension and coronary artery disease. His family history was notable for Sjögren’s syndrome and systemic lupus erythematous (SLE). He had a history of smoking tobacco, but denied alcohol or illicit drug use.

On our initial physical examination, the patient had normal vital signs. Despite his complaints of dyspnea and orthopnea, he had normal pulmonary and cardiac examinations. The muscle strength in his right upper arm was 3/5, and he had pitting edema on his lower extremities.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The examination of the patient’s skin was notable for livedo reticularis and ulceration of the lower extremities, extending from the calves to the heels of his feet (see Figure 1, above). The ulcers were of varying stages, with some being early stage and superficial, and other lesions deep with eschar formation.

Laboratory analysis is listed in Table 1.

Table 1: Laboratory Test Results

LaboratoryTest Result*Reference Range
White cell count11.6 K/uL4.8–10.8 K/uL
Serum eosinophil %0.0360.0–6.1%
Serum eosinophil (number)0.4 K/uL0.0–0.4 K/uL
Hemoglobin12.4 g/dL14–18 g/dL
Platelet385 K/uL140–420 K/uL
Serum creatinine0.9 mg/dL0.6–1.3 mg/dL
Aspartate aminotransferase (AST)21 IU/L15–41 IU/L
Alanine aminotransferase (ALT)35 IU/L12–63 IU/L
Creatine phosphokinase (CPK)110 IU/L25–250 IU/L
C-reactive protein1.63 mg/dL0–0.6 mg/dL
Erythrocyte sedimentation rate62 MM/HR0–15 MM/HR
Anti-nuclear antibody (ANA)1:640 titer (nucleolar)<1:80 titer
Anti-proteinase 3 (anti-PR3)<3.5 U/mL0.0–3.5 U/mL
Anti-myeloperoxidase (anti-MPO)<9.0 U/mL0.0–9.0 U/mL
Anti-double-stranded DNA (anti-dsDNA)NegativeNegative
Interleukin-62.4 pg/mL0.0–15.5 pg/mL
Interleukin-2<31.2 pg/mL0.0–31.2 pg/mL
IgE, Total779 IU/mL6–495 IU/mL
C3 complement117.0 mg/dL90–180 mg/dL
C4 complement28.0 mg/dL10–40 mg/dL
Hepatitis B surface antigenNonreactiveNegative
Hepatitis C antibodyNonreactiveNonreactive
HIV screen (AB/AG combo)NonreactiveNonreactive
B-type natriuretic peptide12 pg/mL0–100 pg/mL
Urine bloodNegativeNegative
Urine proteinNegativeNegative
*abnormal findings indicated in bold

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Vasculitis Tagged With: case report, dyspnea, polyarteritis nodosa, shrinking lung syndromeIssue: March 2022

You Might Also Like:
  • Case Report: Diagnosing, Treating Hepatitis B-Linked Polyarteritis Nodosa
  • Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa
  • Kussmaul, Meier & Polyarteritis Nodosa
  • Case Report: Drug-Induced Lupus & ANCA-Associated Vasculitis Overlap

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)